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Induction and Inhibition of Pseudomonas
aeruginosa Quorum Sensing
by Synthetic Autoinducer Analogs
protected from the patient’s immune system and less
susceptible to drug treatments.
P. aeruginosa uses a quorum-sensing (QS) mecha-
nism of gene regulation to control expression of these
virulence factors [6, 8–11]. First discovered in the marine
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Buffalo, New York 14260 which bacterial communities can communicate to rap-
idly alter gene expression based on cell population den-
sity [12]. Small amounts of a secreted signaling com-
pound called an autoinducer (AI) accumulate withSummary
increasing population density (reviewed in [13]). These
compounds pass between cells and, when present atWe synthesized a library of Pseudomonas aeruginosa
concentrations representative of a “quorum,” bind a reg-autoinducer analogs with variation targeted to the ho-
ulatory protein, thereby activating it as a transcriptionmoserine lactone (HSL) moiety and discovered a new
factor. The regulatory protein is a member of the LuxRagonist, 3-oxo-C12-(2-aminocyclohexanol), capable of
family of transcription factors, and targets for transcrip-activating LasR as a transcription factor. We recon-
tional activation include genes encoding the LuxR pro-structed two sets of focused libraries against the quo-
tein and the autoinducer synthase, a LuxI homolog. Thisrum-sensing transcription factors LasR and RhlR, re-
creates a positive feedback, autoinducing loop.spectively. Opposing the prediction that both proteins
The QS system in P. aeruginosa is controlled by twoshould have the same binding site for HSL, it was
distinct yet interrelated pathways [14], the las and rhlsurprising to find that these two related proteins re-
systems. This organism possesses two LuxR type pro-spond to different structural motifs. This suggests that
teins, LasR and RhlR, and two LuxI type AI synthasethe HSL binding site differs in these proteins. We also
proteins, LasI and RhlI. The AI compound produced byfound that subtle structural modifications to the ago-
the I proteins is an N-acyl-homoserine lactone. Each Inists yielded compounds with antagonist activity. We
protein produces a compound with a unique acyl chainperformed a series of assays to show that inhibition
(reviewed in [15]), and each AI compound is sensedof quorum sensing by these antagonists significantly
reduced the production of virulence factors and bio- specifically by binding with high affinity to its cognate
film formation. R protein. In P. aeruginosa, LasI synthesizes AI1 (3-
oxo-C12 HSL) [16], which activates LasR. Similarly, RhlI
synthesizes AI2 (C4 HSL) [17], which activates RhlR. TheIntroduction
LasR protein is the first to be activated, and it controls
expression of the RhlR pathway via transcriptional acti-Pseudomonas aeruginosa is known to cause serious
vation of rhlR [18] and possibly rhlI [19], and putativelyinfections in certain immunocompromised individuals
posttranslationally by binding of the LasI product (AI1)(reviewed in [1]). As one of the most frequent nosocomi-
to the RhlR protein [18]. This prevents activation of RhlRally acquired pathogens, it infects cancer patients re-
by AI2 in the early stages of QS activation when AI2ceiving chemotherapy, burn patients, those on ventila-
concentrations are very low. In addition to inducing tran-tors or with catheters, AIDS patients, and others. Most
scription of genes encoding QS proteins, LasR and RhlRnotably, it is the cause of mortality in nearly all individu-
each have numerous gene targets, most of which codeals with cystic fibrosis (CF), the most common fatal ge-
for proteins involved in the disease process or necessarynetic disorder in the U.S. [2]. Abnormalities in the lung
for survival within a host [6, 8, 14].tissue of CF patients allow P. aeruginosa colonization,
causing prolonged inflammation, tissue damage, and There now exists overwhelming evidence that QS is
eventually respiratory failure. required for P. aeruginosa to cause disease [4, 9, 20–25].
The unusually large P. aeruginosa genome [3] facili- Disruption of QS genes or elimination of specific QS-
tates its adaptability to varied environments, and thus controlled virulence factors results in less severe, treat-
it is found ubiquitously and is nearly impossible to elimi- able infections. Since conventional antibiotic therapies
nate from hospital environments. Also encoded in its lack the efficacy to deal with chronic P. aeruginosa infec-
genome is a suite of virulence factors that contribute tions, new targets for alternative therapies are needed.
to pathogenicity, including secreted proteases, toxins, Because QS is required for pathogenicity, it is an ideal
hemolysins, and an exopolysaccharide that composes target for drug design [26–29]. The LasR protein is con-
biofilm [4–6]. Formation of biofilm, where cells attach to sidered the “master regulator” of QS as activation of
tissue and then secrete a slimy polysaccharide matrix LasR by AI1 initiates the QS cascade. The LasR protein
to encase the bacterial community, is one of the most has been difficult to purify in an active form, and there-
challenging problems in treating chronic P. aeruginosa fore its structure has not been determined. This means
infections [7]. Once this structure forms, the colony is that neither a cell-free in vitro assay system for the
discovery of antagonists nor knowledge for rational de-
sign of antagonists is available. Therefore, cell-based*Correspondence: hsuga@buffalo.edu
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screening of random analog libraries is the only available
method to discover antagonists.
Previous work to isolate autoinducer antagonists fo-
cused on altering the side chain [26, 30]. These attempts
provided evidence that the length of the side chain can
be altered somewhat with little effect on activity, but
drastic changes of length or substitution with bulky
groups proximal to the HSL group eliminates activity. No
potent antagonists were discovered from these studies.
Since HSL is the common structural element in all AIs
Figure 1. Chemical Structures of Autoinducers and Analogsfrom LuxR/LuxI-type QS systems, it likely plays a critical
AI1, 3-oxo-C12HSL; AI2, C4 HSL; 1, 3-oxo-C12-(2-aminocyclopentanone);role in inducing R protein activity. However, the struc-
2, 3-oxo-C12-(2-aminocyclopentanol); 3, 3-oxo-C12-(2-aminocyclo-tural elements of the HSL required for R protein activa- hexanone); 4, 3-oxo-C12-(2-aminocyclohexanol); 5, C4-(2-aminocy-
tion have not been explored. Very few AI analogs with clopentanone); 6, C4-(2-aminocyclopentanol); 7, C4-(2-aminocyclo-
alterations at the HSL moiety have been synthesized hexanone); 8, C4-(2-aminocyclohexanol).
and tested for biological activity. Among these, only
substitution of HSL with homocysteine lactone exhibited
To explore further the requirements for LasR bindinga comparable activity to P. aeruginosa AI1 [30]. Clearly
and activation, we chose to focus on the most activemuch work needs to be done before we have sufficient
compound, 3-oxo-C12-(2-aminocyclohexanol) (Figure 1,knowledge of the R protein-HSL interaction to design
4), which was able to induce GFP at concentrationseffective QS inhibitors.
comparable to the natural AI1 (Figures 2A and 2B, 4).Very recently, progress has been made on the path
Superimposition of the amino and hydroxyl groups into elucidate the structure of R proteins. The crystal
this molecule with the amino and keto groups in HSLstructure of TraR, the LuxR homolog from Agrobacter-
suggests similarities in structure. This led us to hypothe-ium tumefaciens, complexed with its AI and DNA, was
size that a 5- or 6-membered ring with a keto or hydroxlpublished [31]. The crystal shows the HSL ring keto
group (or other hydrogen bond acceptor) adjacent togroup in a hydrogen bond with Trp57. This residue as
the amine is sufficient for both binding and activationwell as Asp70 and Tyr53, which interact with the amide
of LasR. To test this hypothesis, we synthesized thegroup of the acyl-HSL linkage, are conserved in both
series of molecules shown in Figure 1 (compounds 1–3).LasR and RhlR. However, the AI binding site is not com-
We were also interested in whether analogs binding topletely conserved between the published structure of
one R protein could bind other R proteins simply byTraR and either LasR or RhlR, and neither LasR nor RhlR
substituting the cognate side chain. We therefore syn-is strongly activated by the A. tumefaciens AI, 3-oxo-
thesized a second series of molecules (Figure 1, 5–8)C8-HSL [30]. The variability in AI structure conferring R
with C4 side chains and tested their ability to activateprotein specificity is limited to the length and substitu-
RhlR using an rhlI-gfp reporter strain, PAO-JP2 (prhlI-tions of the acyl side chain [11]. Does this suggest that
LVAgfp) [32].all R proteins bind the HSL moiety in a similar manner?
Can we modify the HSL structure in such a way as to
Results and Discussioncreate a general antagonist that can be applied to all
R proteins simply by substituting the appropriate acyl
Reporter Gene Assayschain? The answer to these questions will aid in the
Using the PAO-JP2 (plasI-LVAgfp) reporter strain, werational design of analogs that can bind and inhibit R
first tested activity of the 3-oxo-C12 molecules, AI1 andproteins in organisms such as P. aeruginosa and others
1–4. Strong QS induction by AI1 was evidenced by theof medical and economic importance that use QS to
high GFP signal observed at as low as 1 M of AI1regulate essential life processes.
(Figures 2A and 2B, AI1). Our previously identified ago-To explore the above questions, we synthesized a
nist, 3-oxo-C12-(2-aminocyclohexanol) 4, showed stronglibrary of AI1 analogs in which the 3-oxo-C12 side chain
agonist activity with GFP induction only 2-fold less thanwas retained and the HSL group was altered to various
AI1 at 1 M and comparable to AI1 at higher concentra-amines and alcohols (a total of 96 molecules were syn-
tions (Figures 2A and 2B, 4). 3-oxo-C12-(2-aminocyclo-thesized) (Y.B., K.M.S., and H.S., unpublished data). To
pentanone) 1 is structurally more similar to AI1 than 4,screen our library for biological activity, we used a P.
since the oxygen of HSL was simply replaced with car-aeruginosa strain in which both AI synthase genes had
bon in 1. Hence, we expected that 1 would have strongbeen knocked out (PAO-JP2, lasI, rhlI) [14] harboring
agonist activity. Contrary to this prediction, 1 was ableplasmid plasI-LVAgfp [32]. When grown in the presence
to induce the reporter only at a very high concentrationof exogenously added AI1, the LasR-AI1 complex acti-
(Figures 2A and 2B, 1). Even more surprising, com-vates transcription of the lasI promoter that controls
pounds 2 and 3 were nearly unable to induce the re-gfp expression. This provides a simple, high-throughput
porter, even at high concentrations (Figures 2A and 2B,method to detect the activity of analogs by measuring
2 and 3).fluorescence. The compounds in the library were
The C4 compounds (A12 and 5–8) were analyzed forscreened for their ability to activate expression of GFP.
agonist activity using PAO-JP2 (prhlI-LVAgfp) (FiguresSeveral novel agonists were discovered, and this
2C and 2D). Induction of GFP expression in this reporterscreening result is reported elsewhere (Y.B., K.M.S., and
H.S., unpublished data). requires addition of both AI1 and AI2. The AI2 control
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Figure 2. Reporter Gene Induction by Autoinducers and Their Analogs
(A) Molecular Imager scan of 96-well plate containing PAO-JP2 (plasI-LVAgfp) in the presence of 1, 100, and 400 M of the designated 3-oxo-
C12 compound.
(B) Quantification of results of 3-oxo-C13 compounds. Cont, negative control of untreated cell (not shown in [A]). Average fluorescence of four
replicate wells was corrected for cell density by dividing by OD600 of cell culture. The standard deviation was derived from three independent
experiments shown in (A).
(C) Molecular Imager scan of 96-well plated containing PAO-JP2 (prhlI-LVAgfp) in the presence of 1 M AI1 and 10, 100, and 400 M designated
C4 compound.
(D) Quantification of results of C4 compounds. Data analysis was the same as (B).
and agonist assays, therefore, were performed in the 1 is a weak agonist, and 2-aminocyclohexanone 3 has
no agonist activity. Thus, based on our results, we pro-presence of 1 M AI1 and increasing concentrations of
AI2 or analog (Figures 2C and 2D). Both ketone deriva- pose that the microenvironment of the protein-HSL in-
terface differs between LasR, RhlR, and TraR.tives, 5 and 7, showed strong agonist activity, inducing
the reporter at just 10 M (Figures 2C and 2D, 5 and 7). The most intriguing observation is that a subtle struc-
tural change from hydroxyl to keto group on the cyclo-In contrast, the 2-aminocyclopentanol derivative 6 had
no agonist activity. Moreover, the 2-aminocyclohexanol hexane ring (4→ 3), or from keto to hydroxyl group on the
cyclopentane ring (1 → 2 or 5 → 6), drastically reducedderivative 8 had very little AI2 agonist activity; it could
induce only moderate GFP expression at 400 M (Fig- agonist activity. It is unlikely that such a small structural
difference would completely eliminate binding to theures 2C and 2D, column 8).
As mentioned above, we initially assumed that since respective R protein. A more likely, alternative explana-
tion is that the cyclopentanol (2) and cyclohexanone (3)2-aminocyclopentanone (1 and 5) and 2-aminocyclohex-
anone (3 and 7) have a keto group, they would better compounds can still bind LasR with similar affinity but
are unable to activate it. Therefore, we speculated thatmimic the HSL structure than 2-aminocyclopentanol (2
and 6) and 2-aminocyclohexanol (4 and 8). In fact, in compounds 2 and 3 might act as AI1 antagonists. Simi-
larly, compound 6 should maintain the ability to bindthe rhl circuit, the ketone derivates are better agonists
of AI2 than the alcohol derivatives. This is also consis- RhlR and therefore might act as an AI2 antagonist.
tent with the crystal structure of the TraR-3-oxo-C8 HSL
complex, which shows the ketone participating in an H Antagonist Assays
Based on the above hypothesis, we performed a compe-bond. Presumably, an alcohol substitution could main-
tain the H bond, but less efficient binding would be tition assay of 2 and 3 against AI1, using strain PAO-
JP2 (plasI-LVAgfp). As predicted, compound 2 inhibitedexpected. The results for the AI1 analogs, however, do
not fit this pattern. In the las circuit, 2-aminocyclohexa- GFP expression approximately 70% at a 100-fold excess
concentration over AI1 (Figure 3A), and compound 3nol 4 is the strongest agonist, 2-aminocyclopentanone
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ing results were obtained from the assay of compound
3, where GFP expression of the rhlI-gfp reporter was
inhibited by greater than 60% at 50M when competing
against 1 M AI1 and 10 M AI2 (Figure 3B).
Inhibition by compound 3 of the rhlI-gfp reporter was
greater than that seen with the lasI-gfp reporter. Results
from the lasI-gfp assay suggest that 3 inhibits LasR-
AI1-dependent activation of transcription (Figure 3A).
Since the rhlR promoter is also activated by LasR-AI1,
inhibition of rhlI-gfp in the presence of 3 is likely due
to inhibition of LasR-AI1-dependent activation of rhlR
expression. This then translates into reduced activation
of RhlR-AI2-dependent rhlI-gfp expression. It is also
possible, however, that 3 directly interacts with RhlR
and prevents AI2 binding, since AI1 is able to act as an
antagonist against RhlR and prevent binding by AI2 [18].
The AI2 analog with the same ring structure as com-
pound 3 (compound 7, 2-aminocyclohexanone) is a
strong agonist of RhlR. This supports the speculation
that 3 could enter the AI binding site of RhlR and antago-
nize the RhlR-AI2 interaction. The chain length of RhlR
autoinducers appears to be the determining factor regu-
lating RhlR activation, since C4HSL activates RhlR butFigure 3. Antagonist Assays
3-oxo-C12HSL antagonizes it, and no C4 analogs have(A) GFP expression by PAO-JP2 (plasI-LVAgfp) in the presence of
1 M AI1 alone (control, black bar) or 1 M AI1 plus 2 or 3. been identified that can antagonize it. Regardless of the
(B) GFP expression by PAO-JP2 (prhlI-LVAgfp) in the presence of mechanism of inhibition by compound 3, since the rhlI
1 M AI1 and 10 M AI2 (control, black bar) or 1 M AI1 and 10 target is further downstream in the LasR signaling path-
M AI2 plus 2 or 3. way than lasI, we would expect to see stronger inhibition
of rhlI than lasI.
had a lesser inhibitory effect (35% reduction) under the
same conditions. It should be noted that this inhibition Virulence Factor Assays
In order to provide further evidence that compounds 2experiment was performed with competition against 1
M AI1, a concentration typically produced by wild- and 3 are disrupting QS, we tested their ability to reduce
expression of virulence factors in both the AI synthasetype P. aeruginosa [17]. These results suggest that both
molecules bind LasR and prevent it from being activated knockout (PAO-JP2) and wild-type (PAO1) P. aeruginosa
strains. We chose to assay two important virulence fac-by AI1. This view is supported by the compounds’ inabil-
ity to inhibit GFP expression when the lasI promoter is tors in Pseudomonas infections: first, the pigment pyo-
cyanin that is required for disease in the Arabidopsisreplaced with a lac promoter in strain PAO-JP2 (pTdK-
GFP) [32] (data not shown). It should also be noted that thaliana [34], Caenorhabditis elegans [4], and Galleria
mellonella [35] infection models and causes serious tis-cell growth was not affected by the addition of 2 or 3
at concentrations up to 400 M (data not shown). Thus, sue damage in chronic lung infections [36]; second, the
metalloprotease elastase B, which degrades immuneit appears that compounds 2 and 3 act as specific inhibi-
tors of QS-controlled promoters. Compound 6 was also components and causes tissue damage [37].
Strong induction of pyocyanin in P. aeruginosa PAO-tested for its ability to compete against AI2, but no inhibi-
tion of the rhlI-gfp reporter gene was seen (data not JP2 requires addition of both AI1 and AI2 (Figures 4A
and 4B). When compound 3 was added in combinationshown).
Next, we tested the ability of 2 and 3 to inhibit the with exogenous AIs, there was nearly complete inhibi-
tion of pyocyanin expression (Figures 4A and 4B). A veryrhlI-gfp reporter strain PAO-JP2 (prhlI-LVAgfp), since
this expression is also AI1 dependent. The Iglewski similar inhibitory effect by 3 was observed when wild-
type P. aeruginosa (PAO1) was assayed (Figure 4C). Thegroup recently reported that the rhlI promoter is induced
primarily by the LasR-AI1 complex [19], but we see no concentration-dependent inhibitory effect of 3 leads us
to believe that 3 is specifically competing against AIinduction of this promoter with the addition of only AI1
(data not shown). It is possible that the rhlI-lacZ reporter activation of pyocyanin expression. Compound 2, on
the other hand, reduced pyocyanin expression by 50%used in their study is more sensitive than the rhlI-gfp
construct used in our study, and the small amount of in PAO-JP2 (Figures 4A and 4B), but the inhibition was
not concentration dependent over the range tested.GFP induced by AI1 is below our limit of detection.
However, since both AI1 and AI2 are required to induce Moreover, 2 had no significant effect on PAO1 (Figure
4C). We therefore think that the inhibitory effect of 2 onGFP from the PAO-JP2 (prhlI-LVAgfp) reporter, we inter-
pret our data in the context of earlier experiments that pyocyanin expression is not as significant as that of 3.
For the elastase B assay, a colorimetric assay wasshowed predominantly RhlR-AI2 activation of the rhlI
promoter [33]. Surprisingly, compound 2 showed no an- conducted using elastin congo red substrate, so the
observed protease activity is predominantly due to elas-tagonist activity in this assay (Figure 3B). More promis-
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Figure 4. Virulence Factor Assays
(A) Pyocyanin expression by PAO-JP2. ,
negative control; , positive control, 25 M
each of AI1 and AI2; 2, 25 M each of AI1
and AI2 in the presence of 100 M 2; 3, 25
M each of AI1 and AI2 in the presence of
100 M 3.
(B) Quantification of pyocyanin expression by
PAO-JP2 in the presence of various concen-
trations of 2 or 3. , negative control con-
taining no AIs (black bar); , positive control
containing 25 M each of AI1 and AI2 (purple
bar); 2, 25 M each of AI1 and AI2 in the
presence of 2; 3, 25 M each of AI1 and AI2
in the presence of 3.
(C) Quantification of pyocyanin expression of
wild-type strain PAO1. The conditions are the
same as (B), except for control (purple bar)
where no AIs were added.
(D) Elastase B activity produced by PAO-JP2
in the absence (negative control, black bar) or
presence of 5 M AI1 and 10 M AI2 (positive
control, purple bar) or 5 M AI1 and 10 M
AI2 plus 2 or 3.
(E) Elastase B activity produced by PAO1
control (purple bar) or in the presence of 2
or 3.
tase B and not other proteases that might be present biofilm formation [32]. Strain PAO-JP2 (pTdK-GFP) [32]
contains a constitutively expressed GFP construct forin culture supernatants (Figures 4D and 4E) [38]. Our
control experiment showed that 5 M AI1 and 10 M visualization by scanning confocal laser microscopy.
The PAO-JP2 autoinducer synthase knockout strain didAI2 were required for consistent induction of elastase
B activity in PAO-JP2. At 50 M 3, elastase activity was not form a biofilm unless AIs were added (Figure 5A).
When this strain was grown in the presence of AIs plusreduced to 60% of the positive control level (Figure 4D).
When the same assay was performed on wild-type P. 3, biofilm formation was completely inhibited (Figure 5A,
right panel). Inhibition of biofilm formation in the wild-aeruginosa, elastase activity was reduced to 30% of the
control level in the presence of 100 M 3 (Figure 4E). type strain PAO1 (pTdK-GFP) (Figure 5B) was less obvi-
ous, but there was a noticeable difference in biofilmThese results indicate that 3 likely inhibits elastase B
expression, although the inhibition was not as strong morphology when grown in the presence of 3. The above
results provide additional evidence that compound 3as that observed for pyocyanin expression. On the other
hand, compound 2 had no significant effect on elastase interferes with QS signaling and reduces the production
of important virulence factors.activity produced by either strain (Figures 4D and 4E).
Since 2 showed weaker inhibition of pyocyanin and elas-
tase production than 3, future studies focused solely
Conclusions and Outlookon 3.
The initial screen of our library yielded a potent agonist
of AI1, and we elaborated this compound further to sup-
port our hypothesis that the HSL ring could be agonizedStatic Biofilm Assay
There is evidence that the chronic nature of P. aerugi- by a 5- or 6-membered ring system with a hydrogen
bond acceptor at position 1 (hydroxyl or oxo group).nosa infections is due in part to biofilm growth [39, 40].
Biofilm is an attached colony of bacteria protected from We targeted both the las and rhl systems in this study,
synthesizing the same compounds with either a 3-oxo-biocide treatment and the host immune response by a
secreted polysaccharide matrix [41]. Its development in C12 side chain or a C4 side chain. The results of the study
of agonist activity of the analogs were unexpected. WeP. aeruginosa is QS controlled, and disruption of QS
has been shown to eliminate or reduce biofilm develop- found that the requirements for binding of AI differ be-
tween the homologs LasR and RhlR. LasR was activatedment [22, 25, 42]. Prevention of biofilm growth continues
to be a challenge, since treatment of biofilm colonies best by 3-oxo-C12-(2-aminocyclohexanol), and RhlR was
activated equally well by C4-(2-aminocyclopentanone)has proven extremely difficult.
We tested compound 3 for its effect on biofilm devel- and C4-(2-aminocyclohexanone). Our results suggest
that even though all I proteins synthesize an acylatedopment in a 24 hr assay that looks at the early stages
of biofilm formation. The static biofilm assay is a simple HSL, the R proteins do not necessarily recognize the
HSL moiety in the same manner. Further elaboration ofyet reliable method to monitor QS-controlled steps of
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Figure 5. Static Biofilm Assay
(A) PAO-JP2 (pTdK-GFP) biofilm development in the presence of designated compounds.
(B) PAO-1 (pTdK-GFP) biofilm development in the absence (negative control) or presence of 50 M 3.
the structure of these synthetic agonists may provide agonize the las cascade. Future studies will focus on
discovery of a specific AI2 antagonist that could benew insights into the specificity of the R protein-AI inter-
action. used in combination with our AI1 antagonist or a single
compound capable of inhibiting both LasR and RhlR. ItWhile attempting to elucidate structural elements re-
quired for agonist activity, we found compounds with is necessary to discover such antagonists since both
cascades need to be eliminated for effective QS inhibi-antagonist activity. Compound 2, 3-oxo-C12-(2-amino-
cyclopentanol), inhibited the lasI-gfp reporter very effec- tion, as there is evidence that the rhl cascade can be-
come activated in the absence of the las cascade undertively but had no effect on the rhlI-gfp reporter and was
only mildly effective at disrupting QS-regulated viru- certain selective conditions [43].
The most active P. aeruginosa AI1 antagonist pre-lence factor expression. Why did compound 2 fail to
exhibit inhibitory action in the rhlI-gfp reporter and viru- viously identified, recently reported by Hentzer et al. [27],
is derived from the halogenated furanones of Delissealence factor assays? Our current hypothesis relates to
the issue raised in the discussion that 3 may directly pulchra. This compound displays similar properties to
our compound 3 in that it inhibits QS at roughly 100-bind RhlR and prevent AI2 binding. Compound 2 may
be unable to interact with RhlR, so its QS inhibitory fold excess concentrations over the natural AIs. It is
difficult to make direct comparisons of the activity ofactivity is mediated purely through disruption of the
LasR-AI1 interaction. This speculation is supported by these compounds, however, since different promoters
were used to control the reporter systems that deter-the fact that the AI2 analog with the same ring structure
as 2 (compound 6, 2-aminocyclopentanol) does not acti- mined activity. It should be noted that Whiteley et al.
grouped QS promoters into four classes based on theirvate RhlR. The AI binding site of RhlR, therefore, cannot
accommodate a cyclopentanol ring (2 or 6), but can responsiveness to AI1 versus AI2, and the degree and
timing of that response [6]. Class I promoters, whichaccommodate a cyclohexanone ring (3 and 7). These
questions require further study. include the lasI promoter used in our reporter assay, are
induced early after a quorum is reached and respondCompound 3, 3-oxo-C12-(2-aminocyclohexanone), in-
hibited both the lasI and rhlI reporters, pyocyanin, elas- strongly to only AI1. The lasB promoter used in the
Hentzer study is a class IV promoter that requires bothtase, and biofilm. While 3 appears to inhibit the rhl cas-
cade somewhat, it was disappointing that none of the AI1 and AI2 for full induction and responds very little to
AI1 alone. Perhaps this is not relevant when inhibitionAI2 analogs showed antagonist activity toward the rhl
cascade. AI1 has weak antagonist activity toward RhlR assays are performed in heterologous systems lacking
other regulators of QS-controlled genes, but we should[18], as might 3, following the general trend that long
chain AIs antagonize R proteins that are activated by cautiously consider this when comparing data collected
in P. aeruginosa. We think our system using a class Ishort chain AIs [26]. We currently lack a potent antago-
nist for the rhl cascade, particularly one that does not promoter is more difficult to inhibit, so our antagonist
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(s, 1H), 7.40 (s, 1H); 13C (125 MHz, CDCl3): 14.1, 21.3, 22.6, 23.3,may be more active than the Hentzer antagonist. Addi-
28.95, 29.20, 29.30, 29.35, 30.3, 31.8, 32.6, 44.0, 47.9, 60.7, 79.5,tionally, we saw inhibition of QS at physiologically rele-
167.5, 207.4; EI-HRMS calcd for C17H31O3N (M) 297.2298, foundvant AI concentrations, where both natural AIs were at
297.2299. Enol form: IR (KBr) 2918, 2952, 1655, 1424, 1365, 832
or above 1 M [17]. Indeed, the concentrations used in cm1; 1H NMR (500 MHz, CDCl3)  0.88 (t, J  7.5 Hz, 3H), 1.20–1.38
our studies were much higher than those typically used (m, 12H), 1.52 (m, 2H), 1.62 (m, 1H), 1.78–1.96 (m, 3H), 2.15 (td, J 
7 Hz, 1.5 Hz, 2H), 2.30 (m, 2H), 3.56 (m, 1H), 4.27 (m, 1H), 5.03 (d,in similar inhibition studies. It should also be noted that
J  1.5 Hz, 1H), 6.82 (s, 1H); 13C (125 MHz, CDCl3)  14.1, 21.1, 22.6,a primary advantage to our antagonist is the ease of
27.6, 28.9, 29.24, 29.29, 29.42, 30.66, 30.69, 31.8, 36.6, 57.3, 87.8,synthesis of new analogs. The 3-oxo-C12-(2-aminocyclo-
98.2, 165.6, 168.7; EI-HRMS calcd for C17H29O2N (M-H2O) 279.2193,hexanone) structure can easily be manipulated to gener-
found 279.2197.
ate new focused libraries to screen for stronger antago- N-(trans-2-hydroxycyclohexyl)-3-oxododecanamide (4)
nists, and these analogs are expected to have lower The same procedure as the synthesis of 1 was performed, except
that trans-2-amino-cyclohexanol hydrochloride was used insteadtoxicity than the halogenated analogs of D. pulchra.
of trans-2-amino-cyclopentanol hydrochloride. Column chromatog-
raphy of the crude product gave 4 in the ketone form (23 mg, 0.074Significance mmol, Rf  0.29) and enol form (11 mg, 0.035 mmol, Rf  0.17) in
a total of 51% yield. Ketone form: IR (KBr) 3274, 2927, 1715, 1652,
The transcription factors of bacterial QS systems are 1617, 1564 cm1; 1H NMR (500 MHz, CDCl3)  0.88 (t, J  7.5 Hz,
3H), 1.18–1.40 (m, 16H), 1.58 (m, 2H), 1.72 (m, 2H), 1.90–2.10 (m,important targets for efforts toward biocontrol strate-
2H), 2.53 (t, J  7.5, 2H), 3.35 (m, 1H), 3.43 (s, 2H), 3.67 (m, 1H),gies. We identified new agonists of both P. aeruginosa
7.19 (d, J  5 Hz, 1H); 13C (125 MHz, CDCl3)  14.1, 22.6, 23.3, 23.9,AIs that shed light on the unique R protein-AI interac-
24.5, 28.9, 29.21, 29.31, 29.34, 31.2, 31.8, 34.2, 44.0, 48.3, 55.7, 75.2,
tion in each cognate pair. Compounds 1 and 4 activate 167.3, 207.5; EI-HRMS calcd for C18H33O3N (M) 311.2455, found
LasR, while 5 and 7 activate RhlR. The observed varia- 311.2463. Enol form: IR (KBr) 2921, 2853, 1668, 1452, 1040 cm1;
tion in the active HSL analog structures between the 1H NMR (500 MHz, CDCl3)  0.88 (t, J  7.5 Hz, 3H), 1.16–1.60 (m,
18H), 1.75 (m, 2H), 2.00–2.24 (m 4H), 3.25 (m, 1H), 3.84 (m, 1H), 5.023-oxo-C12 and the C4 derivatives clearly suggests that
(d, J  2 Hz), 5.60 (s, 1H); 13C (125 MHz, CDCl3)  14.1, 22.7, 23.2,the microenvironment of the HSL binding site in these
23.4, 27.3, 28.9, 29.27, 29.33, 29.44, 31.5, 31.9, 32.2, 36.8, 54.2, 82.7,R proteins is different. We also discovered a moder-
97.4, 166.1, 167.8; EI-HRMS calcd for C18H31O2N (M-H2O) 293.2349,
ately active AI1 antagonist (2) and a strong AI1 antago- found 293.2357.
nist (3) that inhibits the QS cascade, resulting in re- N-(2-oxocyclopentyl)-3-oxododecanamide (1)
Oxalyl chloride (42.5 l, 0.486 mmol) in 1 ml anhydrous CH2Cl2 wasduced expression of important virulence factors and
cooled to78C under an argon atmosphere, and anhydrous DMSObiofilm. Future studies will be conducted to test the
(69 l, 0.974 mmol) was added via a syringe. The mixture was stirredeffect of compound 3 on pathogenicity in a model host
for 2 min. 2 with the 3,3-ethylenedioxy protective group at the 2-oxo
system. Most importantly, the discovered structural position (83 mg, 0.243 mmol) in 1 ml CH2Cl2 was added via a syringe,
elements that exhibit antagonist activity will lead us and the mixture was stirred for 15 min. To the resulting solution
to rational design of more focused libraries, and the triethylamine (169 l, 1.215 mmol) was added, and the stirring was
continued for 5 min. After warming to room temperature, the reactionknowledge gained from such investigations will aid in
was quenched by the addition of 20 ml 0.1 M HCl. The resultingthe discovery of potent inhibitors of QS.
mixture was extracted with ethyl acetate (3  30 ml), and the com-
bined organic layers were washed sequentially with saturated aque-
Experimental Procedures
ous NaHCO3 and brine. All the extracts were combined, dried
(MgSO4), and concentrated to give the crude intermediate 1 with
the protective group (57 mg). This molecule was treated with 95%
Synthesis of Autoinducer Analogs TFA in the same manner as in the synthesis of 2, and its chromato-
N-(trans-2-hydroxycyclopentyl)-3-oxododecanamide (2) graphic purification on silica gel afforded 1 (42 mg, 0.14 mmol) in
To a solution of 3,3-ethylenedioxydodecanoic acid (55 mg, 0.213 85% yield. IR (KBr) 3244, 2927, 1752, 116, 1651, 1591, 1567 cm1;
mmol) [16] (Y.B., K.M.S., and H.S., unpublished data) and trans- 1H NMR (500 MHz, CDCl3)  0.879 (t, J  7.5 Hz, 3H), 1.20–1.36
2-amino-cyclopentanol hydrochloride (35 mg, 0.256 mmol, pur- (m, 12H), 1.52–1.64 (m, 2H), 1.64–1.76 (m, 1H), 1.80–1.92 (m, 1H),
chased from Aldrich, 52,586-3) in anhydrous DMF (2 ml) was added 2.04–2.16 (m, 1H), 1.98–2.08 (m, 1H), 2.36–2.44 (m, 1H), 2.53 (t, J 
successively EDC (49 mg, 0.256 mmol), DMAP (32 mg, 0.256 mmol), 7.5 Hz, 2H), 2.55–2.69 (m, 1H), 4.12–4.20 (m, 1H), 7.40 (d, J  5 Hz,
and i-Pr2NEt (45 l, 0.256 mmol) at room temperature. The mixture 2H); 13C (125 MHz, CDCl3)  14.0, 18.2, 22.6, 23.3, 28.92, 29.17, 29.28,
was stirred for 18 hr. After removing DMF in vacuo, the residue was 29.31, 29.61, 31.8, 35.0, 43.8, 48.4, 57.8, 166.0, 206.6, 214.5; EI-
dissolved into ethyl acetate (20 ml) and washed with 0.1 M HCl HRMS calcd for C17H29O3N (M) 295.2142, found 295.2145.
saturated with NaCl (20 ml). The aqueous phase was extracted with N-(2-oxocyclohexyl)-3-oxododecanamide (3)
ethyl acetate (3 40 ml). The combined organic extracts were dried The same procedure for the preparation of 1 was used, except that
over MgSO4 and concentrated to give a crude intermediate (57 mg, the starting material was 4 with the 3,3-ethylenedioxy protective
79%). The 3,3-ethylenedioxy protective group was deprotected by group at the 2-oxo position (117 mg, 0.38 mmol). The crude product
treatment of the intermediate dissolved in 1 ml CH2Cl2 with 1 ml was purified by flash chromatography (hexane/EtOAc 1:2, Rf  0.38)
95% TFA for 2 hr at room temperature. The organic solvent was to give 3 (87 mg, 0.28 mmol) in 73% yield. IR (KBr) 3280, 2935, 1712,
briefly removed under reduced pressure, and the residue was mixed 1654, 1628, 1550 cm1; 1H NMR (500 MHz, CDCl3)  0.877 (t, J  7
with saturated aqueous NaHCO3 followed by extraction with ethyl Hz, 3H), 1.20–1.34 (m, 12H), 1.36–1.44 (m, 1H), 1.55–1.70 (m, 3H),
acetate (3  40 ml). The organic layers were combined and washed 1.76–1.84 (m, 1H), 1.84–1.95 (m, 1H), 2.11–2.20 (m, 1H), 2.36–2.44
once with brine and dried over MgSO4. After concentration, the (m, 1H), 2.50–2.60 (m, 3H), 2.60–2.65 (m, 1H), 3.41 (s, 2H), 4.45–4.55
residue was purified by flash chromatography on silica gel to give (m, 1H), 7.53 (d, J  4 Hz, 1H); 13C (125 MHz, CDCl3)  14.0, 22.6,
N-(trans-2-hydroxycyclopentyl)-3-oxododecanamide in the ketone 23.3, 24.0, 27.9, 28.96, 29.20, 29.31, 29.34, 31.8, 35.1, 41.1, 43.7,
form (14.8 mg, 0.050 mmol, Rf  0.42) and the enol form (19.2 mg, 49.2, 58.2, 165.3, 206.0, 207.0; EI-HRMS calcd for C18H31O3N (M)
0.065 mmol, Rf  0.15) in a total of 54% yield. Ketone form: IR (KBr) 309.2298, found 309.2284.
3270, 2921, 1716, 1646, 1613, 1561 cm1; 1H NMR (500 MHz, CDCl3) N-(trans-2-hydroxy)cyclopentylbutanamide (6) and N-(trans-
 0.88 (t, J  7 Hz, 3H), 1.20–1.35 (m, 12H), 1.48–1.52 (m, 1H), 1.58 2-hydroxy)cyclohexylbutanamide (8)
(m, 2H), 1.60–1.78 (m, 2H), 1.81 (m, 1H), 2.05 (m, 1H), 2.16 (m, 1H), The procedure for the preparation of C4-HSL was used for this series
of molecules. The EDC-mediated coupling of butyric acid and trans-2.52 (t, J  7 Hz, 2H), 3.42 (s, 2H), 3.84 (m, 1H), 3.98 (m, 1H), 4.24
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2-amino-cyclopentanol or trans-2-amino-cyclohexanol afforded 6 Microscope (Bio-Rad) with a Nikon Fluor-60 oil emersion objective
lens (NA  1.4), 488 nm argon laser, and OG515 filter.in 66% yield or 8 in 82% yield. 6: IR (KBr) 3284, 2960, 1643, 1567,
1058 cm1; 1H NMR (500 MHz, CDCl3)  0.952 (t, J  7.5 Hz, 3H),
1.40–1.50 (m, 1H), 1.60–1.74 (m, 4H), 1.75–1.82 (m, 1H), 1.96–2.08 Acknowledgments
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